Journals / Turkish Journal of Medical Sciences / 2016 / Cilt: 46 - Sayı: 4

N-terminal-pro brain natriuretic peptide levels in children with allergic rhinitis

Pages
1130–1134
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: These results suggest that NT-proBNP level and PAP may not be affected in children with allergic rhinitis, and primarily this influence may be associated with the severity of nasal obstruction.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Persistent upper airway obstruction may lead to increased pulmonary arterial pressure (PAP).
📊
Key Findings & Data:Materials and methods: Sixty-six patients with allergic rhinitis and 22 healthy children were prospectively enrolled in this study.
💡
Conclusion & Impact:Conclusion: These results suggest that NT-proBNP level and PAP may not be affected in children with allergic rhinitis, and primarily this influence may be associated with the severity of nasal obstruction.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: Persistent upper airway obstruction may lead to increased pulmonary arterial pressure (PAP). The aim of this study was to evaluate N-terminal pro brain natriuretic peptide (NT-proBNP) concentrations and PAP values in children with allergic rhinitis. Materials and methods: Sixty-six patients with allergic rhinitis and 22 healthy children were prospectively enrolled in this study. Plasma NT-proBNP levels were measured at first admission and after treatment. Simultaneously, echocardiography was done to assess pulmonary arterial hypertension, and rhinitis symptom scores were recorded. Results: The median age of the study group was 9.0 (5.0‒17.0) years; 26 were female. PAP was found to be normal in all the patients. There was a negative correlation between age and NT-proBNP levels (r = −0.452, P < 0.01). Nasal blockage levels affected NT-proBNP levels mildly (P = 0.067). No significant difference between before and after nasal steroid treatment was observed in NT-proBNP levels. Conclusion: These results suggest that NT-proBNP level and PAP may not be affected in children with allergic rhinitis, and primarily this influence may be associated with the severity of nasal obstruction.

🔖

Cite This Article

KAYIŞ, S. A., KAYA, F., VATANSEV, H., ORAN, B., ÇİMEN, D., ARTAÇ, H., ARSLAN, D. (2022). N-terminal-pro brain natriuretic peptide levels in children with allergic rhinitis. Turkish Journal of Medical Sciences, Cilt: 46 - Sayı: 4, 1130–1134. https://ajindex.com/articles/610794

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Wallace DV, Dykewicz MS, Bernstein DI, Blessing-Moore J, Cox L, Khan DA, Lang DM, Nicklas RA, Oppenheimer J, Portnoy JM et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 2008; 122: S1-84
  2. Jáuregui I, Dávila I, Sastre J, Bartra J, del Cuvillo A, Ferrer M, Montoro J, Mullol J, Molina X, Valero A. Validation of ARIA (Allergic Rhinitis and its Impact on Asthma) classification in a pediatric population: the PEDRIAL study. Pediatr Allergy Immunol 2011; 22: 388-392
  3. Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richard AM. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000; 355: 1126-1130
  4. Reisli I, Oran B, Baspınar O, Baysal T, Karaaslan TS. Pulmonary arterial pressure in children with allergic rhinitis. Am J Rhinol 2004; 18: 227-232
  5. Yüksel H, Coşkun S, Onağ A. Doppler echocardiographic evaluation of pulmonary arterial pressure in children with allergic rhinitis. Int J Pediatr Otorhinolaryngol 2001; 60: 21-27
  6. Bayrak P, Kirmaz C, Sekuri C, Yuksel H. Is pulmonary arterial pressure affected by allergic rhinitis with nasal obstruction? Asian Pac J Allergy Immunol 2007; 25: 121-126
  7. Nasser N, Perles Z, Rein AJ, Nir A. NT-proBNP as a marker for persistent cardiac disease in children with history of dilated cardiomyopathy and myocarditis. Pediatr Cardiol 2006; 27: 87- 90
  8. Yap LB, Mukerjee D, Timms PM, Ashrafian H, Coghlan JG. Natriuretic peptides, respiratory disease and the right heart. Chest 2004; 126: 1330-1336
  9. Nagaya N, Nishikimi T, Okano Y, Uematsu M, Satoh T, Kyotani S, Kuribayashi S, Hamada S, Kakishita M, Nakanishi N et al. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 1998; 31: 202-208
  10. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica GW, van Weel C et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization GA(2)LEN and AllerGen). Allergy 2008; 86: 8-160
  11. GINA report: Global strategy for asthma management and prevention. Update December 2012. Available from: www. ginasthma.org
  12. Hanafin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Dermatovener (Stockholm) 1980; 92: 44-47
  13. Feigenbaum H. Echocardiography. 5th ed. Lea & Febiger, Philadelphia,